Accessibility Menu
SCYNEXIS logo

SCYNEXIS

(NASDAQ) SCYX

Current Price$0.71
Market Cap$56.01M
Since IPO (2014)-99%
5 Year-93%
1 Year-21%
1 Month-25%

SCYNEXIS Financials at a Glance

Market Cap

$56.01M

Revenue (TTM)

$20.34M

Net Income (TTM)

-$24.52M

EPS (TTM)

-$0.45

P/E Ratio

-1.58

Dividend

$0.00

Beta (Volatility)

1.27 (Average)

Price

$0.71

Volume

12,169

Open

$0.72

Previous Close

$0.71

Daily Range

$0.70 - $0.75

52-Week Range

$0.57 - $1.31

SCYX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SCYNEXIS

Industry

Pharmaceuticals

Employees

18

CEO

David Angulo Gonzalez, MD

Headquarters

Jersey City, NJ 07302-6548, US

SCYX Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-1%

Net Income Margin

-1%

Return on Equity

-53%

Return on Capital

-40%

Return on Assets

-32%

Earnings Yield

-63.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$56.01M

Shares Outstanding

79.44M

Volume

12.17K

Avg. Volume

571.60K

Financials (TTM)

Gross Profit

$20.60M

Operating Income

-$16.07M

EBITDA

-$8.44M

Operating Cash Flow

-$5.28M

Capital Expenditure

$0.00

Free Cash Flow

-$5.28M

Cash & ST Invst.

$21.26M

Total Debt

$2.18M

SCYNEXIS Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$56.01M

N/A

Market Cap/Employee

$2.00M

N/A

Employees

28

N/A

Net Income

-$21.30M

-295.1%

EBITDA

-$16.94M

-224.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$57.20M

+50.1%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$1.56M

-24.5%

Short Term Debt

$504.00K

+18.6%

Return on Assets

-31.58%

N/A

Return on Invested Capital

-39.50%

N/A

Free Cash Flow

-$8.10M

-8.5%

Operating Cash Flow

-$8.10M

-8.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
XCURExicure, Inc.
$3.19+7.41%
NRSNNeuroSense Therapeutics Ltd.
$0.82-4.49%
TLPHTalphera, Inc.
$0.82-0.68%
CVKDCadrenal Therapeutics, Inc. Common Stock
$4.96-0.80%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCEVirgin Galactic
$6.18+0.36%
NOKNokia
$14.84-0.03%
BBAIBigBear.ai
$5.04+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.92-0.03%

Questions About SCYX

What is the current price of SCYNEXIS?

SCYNEXIS is trading at $0.71 per share.

What is the 52-week range for SCYNEXIS?

Over the past 52 weeks, SCYNEXIS has traded between $0.57 and $1.31.

How much debt does SCYNEXIS have?

As of the most recent reporting period, SCYNEXIS reported total debt of $2.06M.

How much cash does SCYNEXIS have on hand?

SCYNEXIS reported $36.75M in cash and cash equivalents in its most recent financial results.

What is SCYNEXIS’s dividend yield?

SCYNEXIS does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.